Addition of single-use Mobius bioreactors to streamline BioInvent's drug development & production
Stada offers a portfolio of high-quality, low-cost generic products including selected biosimilars
Pharma leaders need to take swift steps to get ahead of emerging changes, says Utkarsh Palnitkar
As per the deal, MEDRx to receive upfront payment of about $ 30 mn & will be eligible for royalties
Assocham-Sathguru joint study urges government to reduce the dependency on China for APIs
Two firms had entered into a licensing agreement for investigational drug tildrakizumab in July 2016
Trastuzumab (Herceptin) is one of the 6 biologic products co-developed by Mylan & Biocon
Move clears the way for supply of products from Mohali facility to the US market
US FDA had conducted an inspection at Alkem's Baddi facility from March 2-10, 2017
Merck has a strategic alliance with India's Dr Reddy's Labs to co-develop multiple cancer drugs
It will sell this business to Ascendis Health for Rand 375 million (about Rs 192 crores)
They have signed pact for a generic version of Merck & Co's NuvaRing, a contraceptive vaginal ring
The company has also received US drug regulator's nod for generic Percocet tablet, a pain killer
It has also received approval for clobetasol propionate spray, used for skin treatment
It will enhance Allergan's medical aesthetics portfolio with addition of CoolSculpting system
The move is aimed at reducing the manufacturing cost of drugs and medical devices
UK scientists found that E.coli bacteria increased antibiotic resistance with each treatment
The unit mainly conducted drug discovery research targeting infectious diseases & inflammation
Acquisition significantly enhances Takeda's global oncology portfolio
Tablet is a generic version of MS Contin ER, which had annual US sales of $ 282.9 mn